Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Baxter
Medtronic
Farmers Insurance
QuintilesIMS
Chinese Patent Office
Cerilliant
Covington
Harvard Business School

Generated: April 19, 2018

DrugPatentWatch Database Preview

Claims for Patent: 7,727,548

« Back to Dashboard

Summary for Patent: 7,727,548
Title:Rapidly disintegrable tablet containing polyvinyl alcohol
Abstract:The present invention provides a quickly disintegrating tablet which has quick disintegrability and solubility in an oral cavity, and does not have uncomfortable tastes such as bitterness, has a small variation of a tablet physical property even in storage under a humidifying condition, and has substantially no change in a medicine content in the tablet and tablet appearance and which is superior in stability; and a manufacturing method of the tablet. That is, it provides: a quickly disintegrating tablet which is prepared by blending a medicine with a saccharide and polyvinyl alcohol, which has small variations of tablet weight, tablet hardness, tablet diameter and tablet thickness, and which is superior in medicine stability in the tablet; and a manufacturing method of the tablet.
Inventor(s): Morita; Yutaka (Saitama, JP), Yasui; Masanobu (Saitama, JP), Ohwaki; Takayuki (Saitama, JP), Tsushima; Yuki (Saitama, JP)
Assignee: Eisai R&D Management Co., Ltd. (Tokyo, JP)
Application Number:10/203,687
Patent Claims: 1. A quickly disintegrating tablet comprising a medicine, mannitol and polyvinyl alcohol, wherein the medicine is famotidine, midodrine hydrochloride, brotizolam or donepezil hydrochloride, said quickly disintegrating tablet is compressed, said tablet quickly disintegrates in an oral cavity, a compounding ratio of the mannitol is 0.8 part by weight or more to one part by weight of the tablet, and a compounding ratio of the polyvinyl alcohol is 0.0001 to 0.1 parts by weight to one part by weight of the tablet.

2. The quickly disintegrating tablet according to claim 1, wherein the medicine is donepezil hydrochloride.

3. A method of administering a medicine, said method comprising orally administering a medicine in the form of the quickly disintegrating tablet of claim 1 to a patient in need thereof.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
QuintilesIMS
Healthtrust
Covington
Medtronic
Dow
Cantor Fitzgerald
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.